Drug interactions
Brentuximab vedotin + Dexamethasone
Severity: Minor
Brentuximab vedotin and Dexamethasone: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
The cytotoxic component of brentuximab vedotin (MMAE) is a CYP3A4 substrate, and dexamethasone is a weak to moderate CYP3A4 inducer. MMAE exposure could fall, though the effect is expected to be small and dexamethasone is frequently co-administered in lymphoma regimens.
What this interaction means in plain words
Brentuximab vedotin and Dexamethasone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Brentuximab vedotin belongs to Oncology; Dexamethasone belongs to Endocrine.
Why it happens
Dexamethasone-mediated CYP3A4 induction may increase MMAE metabolism.
What to do
No dose adjustment is generally needed; monitor treatment response.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab vedotin and Dexamethasone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone
- Bcg vaccine live + Dexamethasone Contraindicated
- Dexamethasone + Mifepristone Contraindicated
- Dexamethasone + Rilpivirine Contraindicated
- Dexamethasone + Smallpox vaccine live Contraindicated
- Dexamethasone + Varicella virus vaccine live Contraindicated
- Dexamethasone + Yellow fever vaccine Contraindicated
Other interactions of Brentuximab vedotin
- Bleomycin + Brentuximab vedotin Contraindicated
- Brentuximab vedotin + Siponimod Major
- Apalutamide + Brentuximab vedotin Moderate
- Brentuximab vedotin + Clarithromycin Moderate
- Brentuximab vedotin + Imatinib Moderate
- Brentuximab vedotin + Isoniazid Moderate
Frequently asked questions
Can I take Brentuximab vedotin with Dexamethasone?
MediHelp rates the interaction as minor. Brentuximab vedotin and Dexamethasone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. The cytotoxic component of brentuximab vedotin (MMAE) is a CYP3A4 substrate, and dexamethasone is a weak to moderate CYP3A4 inducer. MMAE exposure could fall, though the effect is expected to be small and dexamethasone is frequently co-administered in lymphoma regimens.
How serious is the interaction between Brentuximab vedotin and Dexamethasone?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is generally needed; monitor treatment response.
What other medicines interact with Dexamethasone?
MediHelp also lists interactions of Dexamethasone with, for example, Bcg vaccine live, Mifepristone, Rilpivirine. The full list is on the Dexamethasone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
